Can the sequence of chemotherapy regimens influence outcome in patients with metastatic pancreatic adenocarcinoma (MPAC)?

被引：1
|
作者：
Schmidt, Shannon Leah
Durkal, Vipal
Jayavalsan, Shinoj Pattali
Ritch, Paul S.
Thomas, James P.
Erickson, Beth
Christians, Kathleen K.
Tsai, Susan
Evans, Douglas B.
George, Ben
机构：
[1] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[2] Froedtert Hosp, Milwaukee, WI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 04期
关键词：
D O I：
10.1200/jco.2016.34.4_suppl.428
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
428
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Association of Antibiotic Receipt With Survival Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma Receiving Chemotherapy
    Fulop, Daniel J.
    Zylberberg, Haley M.
    Wu, Y. Linda
    Aronson, Anne
    Labiner, Arielle J.
    Wisnivesky, Juan
    Cohen, Deirdre J.
    Sigel, Keith M.
    Lucas, Aimee L.
    JAMA NETWORK OPEN, 2023, 6 (03) : E234254
  • [32] A Phase I Study of Ribociclib Plus Everolimus in Patients with Metastatic Pancreatic Adenocarcinoma Refractory to Chemotherapy
    Weinberg, Benjamin A.
    Wang, Hongkun
    Witkiewicz, Agnieszka K.
    Marshall, John L.
    He, Aiwu R.
    Vail, Paris
    Knudsen, Erik S.
    Pishvaian, Michael J.
    JOURNAL OF PANCREATIC CANCER, 2020, 6 (01) : 45 - 54
  • [33] Intra-arterial Chemotherapy in Patients With Metastatic or Locally Aggressive Pancreatic Adenocarcinoma: A Scoping Review
    Basra, Mahi
    Patel, Hemangi
    Biglione, Alejandro
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (05)
  • [34] Implementation of contemporary chemotherapy for patients with metastatic pancreatic ductal adenocarcinoma: a population-based analysis
    Latenstein, Anouk E. J.
    Mackay, Tara M.
    Creemers, Geert-Jan
    van Eijck, Casper H. J.
    de Groot, Jan Willem B.
    Haj Mohammad, Nadia
    Homs, Marjolein Y. V.
    van Laarhoven, Hanneke W. M.
    Molenaar, I. Quintus
    ten Tije, Bert-Jan
    de Vos-Geelen, Judith
    Besselink, Marc G.
    van der Geest, Lydia G. M.
    Wilmink, Johanna W.
    ACTA ONCOLOGICA, 2020, 59 (06) : 705 - 712
  • [35] POLO: Radiologic assessment of the impact of maintenance olaparib in patients (pts) with metastatic pancreatic cancer (mPaC).
    Schwartz, Lawrence Howard
    Kindler, Hedy L.
    Hammel, Pascal
    Reni, Michele
    Van Cutsem, Eric
    Macarulla, Teresa
    Hall, Michael J.
    Park, Joon Oh
    Hochhauser, Daniel
    Arnold, Dirk
    Oh, Do-Youn
    Reinacher-Schick, Anke
    Tortora, Giampaolo
    Alguel, Hana
    O'Reilly, Eileen Mary
    Fromageau, Jeremie
    Ghiorghiu, Dana C.
    McGuinness, David
    Locker, Gershon Y.
    Golan, Talia
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [36] Cross-over comparison and new chemotherapy regimens in metastatic pancreatic cancer
    Kieler M.
    Unseld M.
    Bianconi D.
    Prager G.W.
    memo - Magazine of European Medical Oncology, 2017, 10 (3) : 136 - 140
  • [37] Examination for the Presence of an Oligo-Metastatic State in Patients with Newly Diagnosed Metastatic Pancreatic Adenocarcinoma Undergoing Systemic Chemotherapy
    Ortiz, S.
    Visotcky, A.
    Banerjee, A.
    Aldakkak, M.
    Tsai, S.
    Evans, D. B.
    Christians, K.
    Clarke, C. N.
    George, B.
    Shreenivas, A.
    Kamgar, M.
    Chakrabarti, S.
    Dua, K. S.
    Khan, A. H.
    Erickson, B. A.
    Hall, W. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E66 - E67
  • [38] POLO: Radiologic assessment of the impact of maintenance olaparib in patients (pts) with metastatic pancreatic cancer (mPaC).
    Schwartz, Lawrence Howard
    Kindler, Hedy L.
    Hammel, Pascal
    Reni, Michele
    Van Cutsem, Eric
    Macarulla, Teresa
    Hall, Michael J.
    Park, Joon Oh
    Hochhauser, Daniel
    Arnold, Dirk
    Oh, Do-Youn
    Reinacher-Schick, Anke C.
    Tortora, Giampaolo
    Algul, Hana
    O'Reilly, Eileen Mary
    Fromageau, Jeremie
    Ghiorghiu, Dana C.
    McGuinness, David
    Locker, Gershon Y.
    Golan, Talia
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [39] A randomized, open-label phase II study of nanoliposomal irinotecan (nal-IRI)-containing regimens versus nab-paclitaxel plus gemcitabine in patients with previously untreated metastatic pancreatic adenocarcinoma (mPAC).
    Dean, Andrew
    Chen, Li-Tzong
    Ramanathan, Ramesh K.
    Blanchette, Sarah
    Belanger, Bruce
    Adib, Deyaa
    Bayever, Eliel
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [40] A Case of Metastatic Pancreatic Adenocarcinoma in Complete Remission Using Chemotherapy and Immunotherapy
    Atiq, Saad
    Atiq, Osman O.
    Atiq, Zainab O.
    Samad, Syed
    Atiq, Omar
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (02)
12345